FUNDERS
SELECTED FUNDING
U01 AI169767, NIH/NIAID
Complementing broadly neutralizing antibodies and autologous responses to restrict virus escape and durably suppress HIV-1
Betts and Lynch (PI), Role: PI for Emory subcontract
UM1 AI64562, NIH/NHLBI/NIDDK/NINDS/NIDA/NIAID
Enterprise for Research and Advocacy to Stop and Eradicate HIV (ERASE-HIV)
Paiardini (MPI), Kulpa, and Silvestri (co-PI)
UM1 AI164561, NIH/NHLBI/NIDDK/NINDS/NIDA/NIAID
Reversing Immune Dysfunction for HIV-1 Eradication (RID-HIV)
Chanda (MPI), Cannon, and Sekaly (co-PI), Role: PI for Emory Subcontract
UM1 AI164567, NIH/NHLBI/NIDDK/NINDS/NIDA/NIAID
Collaboratory of AIDS Researchers for Eradication (CARE)
Margolis (MPI), Role: PI for Emory Subcontract
R01 NS126090, NIH/NINDS
Revealing the role of platelets in promoting HIV reservoir seeding and persistence in the CNS-resident myeloid cells
Maggirwar (PI), Role: PI for Emory subcontract
P51 OD011132-60S4, NIH/OD
Role of type-I IFN in regulating COVID-19 induced inflammation and pathogenesis
Role: PI for P51 Supplement
P51 OD011132-60, NIH/OD
Developing an NHP model for understanding the biological causes of long COVID-19
Role: PI for P51 Supplement
R01 MH125457, NIH/NIMH
Determining the relative contribution of CD4 T cells and macrophage to HIV persistence and rebound
Paiardini and Estes (PI)
R56 AI150401, NIH/NIAID
Mobilizing host defenses to lymphoid sites of HIV persistence to induce remission
Paiardini and Lederman (PI)
FastGrants #2144 & #2206, Emergent Ventures/George Mason University
Testing therapeutics to block SARS-CoV-2 replication and COVID-19 pathogenesis in the non-human primates animal model
Paiardini (PI)
The William I.H. and Lula E. Pitts Foundation
Testing antiviral activity of RS-3762
Paiardini (PI)
MP3 SG 2020 COVID-19-3, Emory University
Blocking cell entry with Baricitinib as therapy for 2019-nCoV severe acute respiratory syndrome
Paiardini (PI)
Pilot Grant to P51 OD11132, Yerkes Primate Research Center
Determining SARS-CoV-2 pathogenesis, viral dynamics, and immune responses in nonhuman primate models
Paiardini (PI)
R37 AI141258, NIH/NIAID
Harnessing IL-10 in cART treated SIV infected macaques to restore immunity and to eradicate HIV
Sekaly (PI), Role: PI for Emory subcontract
R21/R33 AI129017, NIH/NIAID
Reducing viral reservoirs by opening HIV-1 Env to antibody attack
Sodroski (PI), Role: PI Emory subcontract
P01 AI131338, NIH/NIAID
Immunological strategies to modulate SIV rebound following ART interruption
Betts and Bar (PI), Role: PI for Emory subcontract
R01 AI129745, NIH/NIAID
Limiting HIV establishment and maintenance by preserving intestinal immunity
Paiardini (PI)
R21 AI122380, NIH/NIAID
Targeting the IL-10 pathway for an HIV cure
Sekaly (PI), Role: PI for Emory subcontract
109354-59-RGRL, amfAR Innovation Grant
Mechanisms and correlates of post-ART treatment control in SIV-infected macaques
Paiardini (PI)
Qura Therapeutics
Co-inhibitory receptor blockade in ART-treated, SIV-infected RMs
Paiardini (PI)
R01 AI116379, NIH/NIAID
Immune based interventions for HIV eradication
Paiardini (PI)
109109-57-RGRL, amfAR
Interleukin-21 therapy to reduce HIV persistence
Paiardini (PI)
R21/R33 AI116171, NIH/NIAID
Targeting cytolytic cells to lymphoid sites of HIV persistence
Paiardini and Lederman (PI)
R01 AI110334, NIH/NIAID
Central memory CD4 T cell infection: key role in ART response and HIV persistence
Paiardini and Marconi (PI)
R21/R33 AI104278, NIH/NIAID
Persistent virus reservoirs in SIV-infected macaques
Paiardini (PI)
R56 AI098625, NIH/NIAID
Double Negative T cells in SIV and HIV Infections
Sodora (PI), Role: PI Emory subcontract
Atlanta Clinical & Translational Science Institute Pilot Award
Central memory CD4 T cell infection in AIDS pathogenesis
Paiardini (PI)
R56 AI091516, NIH/NIAID
Entry coreceptor use and target cell tropism in nonpathogenic SIV infection
Collman (PI), Role: PI Emory subcontract
R01 AI084836, NIH/NIAID
Th17 cells in AIDS pathogenesis and HIV vaccines
Paiardini (PI)
R56 AI087186, NIH/NIAID
Homeostasis of CD4+ T cells in non-human primates
Paiardini (PI)